Browsing: Bio Technology

The Supreme Court has for now preserved access to the abortion medication mifepristone—a win for the biopharma world that rallied…

the FDA handed Biogen, Ionis and particularly superoxide dismutase 1 (SOD1)-ALS patients a victory with the approval of Qalsody—formerly known…

Novartis is doling out $40 million cash for exclusive licensing rights to 3B Pharmaceuticals’ cancer-targeting tech, wrapping up some loose…

Fungi, an integral component of the Earth’s biological system, have long been employed to improve human life. While these creatures…

Biotech companies, including Catalyst Pharmaceuticals Inc., Mersana Therapeutics Inc., and Harmony Biosciences Holdings Inc., are leading peers in revenue growth…

Biotech companies, including Catalyst Pharmaceuticals Inc., Mersana Therapeutics Inc., and Harmony Biosciences Holdings Inc., are leading peers in revenue growth…

With the global electronics industry still reeling from the latest volleys in the semiconductor trade war, biotechnology could become the…

In May of last year, after Seagen rejected Merck’s offer to acquire it for $230 per share, the Seattle biotech…

NKGen Biotech, Inc. (“NKGen”), a clinical stage Natural Killer (NK) cell therapy company, has entered into a merger agreement with…

In the first quarter of 2023, 56 biopharmas laid off staff—an 87% jump compared to 2022, when 30 companies reported…